Abstract Details

Title Tolerability and Effects of Rituximab (Anti-CD20 Antibody) in Neuromyelitis Optica (NMO) and Rapidly Worsening Multiple Sclerosis (MS)

Topic

Presentation(s)

Poster/Presentation
Number 090

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Robin White	No disclosure on file
Samar F. Ahmed, MD	Dr. Ahmed has nothing to disclose.
Ulrich Engelmann	No disclosure on file